Ruconest (C1 esterase inhibitor, recombinant) is a brand-name drug prescribed to treat acute episodes of hereditary angioedema in adults and some children. It’s given as an intravenous (IV) injection ...

Ruconest can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that ...

The price you pay for Ruconest (C1 esterase inhibitor, recombinant) may depend on factors such as your dosage and whether you have health insurance. Financial assistance may be available to help you ...

The US Food and Drug Administration (:FDA) recently accepted the Biologics License Application (:BLA) for Santarus, Inc. (SNTS) and partner, Pharming Group NV’s Ruconest. The companies are looking to ...

The FDA has rejected Pharming’s application to expand the licence of Ruconest, for a use as prophylaxis for patients with the serious rare disease hereditary angioedema (HAE). The FDA asked Pharming ...

If you have heard of Ruconest, but you’re not sure what it is, then keep reading! Ruconest is an entirely manmade type of protein known as a C1 esterase inhibitor. C1 esterase inhibitor naturally ...

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet ...

Ruconest is an intravenous (IV) medication that helps manage sudden swelling episodes in people with hereditary angioedema (HAE). The appropriate dosage of Ruconest for HAE is determined by body ...

The US Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for Santarus, Inc. ( SNTS) and partner, Pharming Group NV's Ruconest. The companies are looking to ...